Europe MRI (Magnetic Resonance Imaging) Market – Industry Analysis and Market Forecast (2019-2026) – by Architecture, Field Strength, Application, and Geography


Europe MRI (Magnetic Resonance Imaging) Market is expected to grow at a CAGR of 4.11% during the forecast period and market is expected to reach US$ 2.5 Bn. by 2027.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

Europe MRI (Magnetic Resonance Imaging) Market

To know about the Research Methodology:-Request Free Sample Report

Europe MRI (Magnetic Resonance Imaging) Market Dynamics:

MRI or magnetic resonance imaging is a non-invasive imaging technology that delivers three-dimensional detailed anatomical images without using radiation that can be harmful. These are often used for disease detection, diagnosis, as well as treatment monitoring. The MRI machines are based on the sophisticated technology that stimulates and detects the transformation in the direction of the rotational axis of protons present in the water and which makes up the living tissues.

Body imaging is gradually becoming one of the fastest growing applications of MRI that comprises of the vascular, pelvic, and cardiac along with the abdominal exams. Challenges remain for the implementation of this technology such as patients having the limited breath-hold capability, general exam complexity, or usability of advanced applications like whole-body imaging.

Functional magnetic resonance imaging or fMRI is increasingly being used for preoperative counselling and planning, along with intraoperative guidance for tumour resection in the eloquent cortex. Although there have been developments in image resolution and artefact correction, there are still various limitations related to this modality.

The accurate correlation of complementary structural and functional images of the human brain (brain mapping) or neurological MRI is now an essential component of studies of brain functional anatomy that has also monitored huge growth in the past few years. Therefore, the brain and neurological has been one of the largest application segments for the Europe MRI (Magnetic Resonance Imaging) Market.

Europe MRI (Magnetic Resonance Imaging) Market Regional Analysis:

Europe is another major region for MRI (Magnetic Resonance Imaging) globally in terms of application where Germany, UK and France are some of the major countries contributing to the overall growth. The MRI procedure is considered indispensable by many physicians, especially when it comes to evaluation of sports-related injuries and for the diagnosis of chronic disease conditions that has been growing a lot in Europe.

An MRI display of the heart and neighboring arteries provide early warning of progressing coronary disease, and also help in locating cancerous tumors making its implementation mandatory across healthcare sector thus boosting the Europe MRI (Magnetic Resonance Imaging) Market growth.

Europe MRI (Magnetic Resonance Imaging) Market, Key Highlights:

• Europe MRI (Magnetic Resonance Imaging) Market analysis and forecast, in terms of value.

• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Europe MRI (Magnetic Resonance Imaging) Market

• Europe MRI (Magnetic Resonance Imaging) Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

• Europe MRI (Magnetic Resonance Imaging) Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

• Europe MRI (Magnetic Resonance Imaging) Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Europe MRI (Magnetic Resonance Imaging) Market are also profiled.

The report has considered the base year of 2019 and past four years trend. 2020 figures are at actuals, however due to different dynamics of year 2020, market forecast is not only dependent upon 2020, but on the basis of 2016-2020.

The Scope of the Europe MRI (Magnetic Resonance Imaging) Market:  Inquire before buying

The research report segments Europe MRI (Magnetic Resonance Imaging) market based on applications, architecture, field strength, and geography.

Europe MRI (Magnetic Resonance Imaging) Market, by Application:

• Spine and musculoskeletal MRI
• Brain and neurological MRI
• Vascular MRI
• Pelvic and Abdominal MRI
• Breast MRI
• Cardiac MRI

Europe MRI (Magnetic Resonance Imaging) Market, by Architecture:

• Open MRI Systems
• Closed MRI Systems
• Standard Bore
• Wide Bore

Europe MRI (Magnetic Resonance Imaging) Market, by Field Strength:

• Low-to-mid Field
• High-field
• 1.5T
• 3T
• Very-high Field

Europe MRI (Magnetic Resonance Imaging) Market, by Geography:

• Europe
• UK
• Germany
• France
• Russia
• Italy
• Spain

Europe MRI (Magnetic Resonance Imaging) Market Key Players

• Alliance Medical UK
• Cobalt Health
• InHealth Group
• Vista Diagnostics
• GE Healthcare
• Hitachi Medical Systems
• Global Diagnostics
• Prime Health
• Everlight Radiology
• Prime Health
• MR Solutions
• Healtis
• Olea medical
• KOELIS
• Sopha
• Metrasens
• Qualiformed
• INUMAC
• MRI Assist
• Affidea Spain
• MRI of Trinidad & Tobago Limited
• Esaote
• Biotronik
• HQ Imaging
• Magritek
• MIPM GmbH

Europe MRI (Magnetic Resonance Imaging) Market, Geographic Analysis:

• Breakdown of UK MRI (Magnetic Resonance Imaging) market
• Breakdown of Germany MRI (Magnetic Resonance Imaging) market
• Breakdown of Italy MRI (Magnetic Resonance Imaging) market
• Breakdown of Russia MRI (Magnetic Resonance Imaging) market
• Breakdown of France MRI (Magnetic Resonance Imaging) market
• Breakdown of Spain MRI (Magnetic Resonance Imaging) market
• Breakdown of Others MRI (Magnetic Resonance Imaging) market

Available Customizations:

Maximize Market Research offers customizations of reports according to the specific requirement of our clients. 





Europe MRI (Magnetic Resonance Imaging) Market

1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY
2.1. Market Definition
2.2. Market Scope
2.3. Data Sources

3. MARKET VARIABLES & SCOPE
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Market Restraint Analysis
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis

4. EUROPE MRI ARCHITECTURE ESTIMATES & TREND ANALYSIS (2019-2026)
4.1. MRI (Magnetic Resonance Imaging) Market: Architecture Analysis
4.2. Open MRI Systems
4.2.1. Open MRI Systems market, 2019-2026 (USD Billion)
4.3. Closed MRI Systems
4.3.1. Closed MRI Systems market, 2019-2026 (USD Billion)
4.4. Standard Bore
4.4.1. Standard Bore market, 2019-2026 (USD Billion)
4.5. Wide Bore
4.5.1. Wide Bore market, 2019-2026 (USD Billion)

5. EUROPE MRI FIELD STRENGTH ESTIMATES & TREND ANALYSIS (2019-2026)
5.1. MRI (Magnetic Resonance Imaging) Market: Field Strength Analysis
5.2. Low-to-mid Field MRI
5.2.1. Low-to-mid Field MRI market, 2019-2026 (USD Billion)
5.3. High-field MRI
5.3.1. High-field MRI market, 2019-2026 (USD Billion)
5.4. 1.5T MRI
5.4.1. 1.5T MRI market, 2019-2026 (USD Billion)
5.5. 3T MRI
5.5.1. 3T MRI market, 2019-2026 (USD Billion)
5.6. Very-high Field MRI
5.6.1. Very-high Field MRI market, 2019-2026 (USD Billion)

6. EUROPE MRI APPLICATION ESTIMATES & TREND ANALYSIS (2019-2026)
6.1. MRI (Magnetic Resonance Imaging) Market: Application Analysis
6.2. Spine and musculoskeletal MRI
6.2.1. Spine and musculoskeletal MRI market, 2019-2026 (USD Billion)
6.3. Brain and neurological MRI
6.3.1. Brain and neurological MRI market, 2019-2026 (USD Billion)
6.4. Vascular MRI
6.4.1. Vascular MRI market, 2019-2026 (USD Billion)
6.5. Pelvic and Abdominal MRI
6.5.1. Pelvic and Abdominal MRI market, 2019-2026 (USD Billion)
6.6. Breast MRI
6.6.1. Breast MRI market, 2019-2026 (USD Billion)
6.7. Cardiac MRI
6.7.1. Cardiac MRI market, 2019-2026 (USD Billion)

7. REGIONAL ESTIMATES & TREND ANALYSIS (2019-2026)
7.1. MRI (Magnetic Resonance Imaging) market share by country, 2016 & 2025
7.1.1. UK
7.1.1.1. UK Medical Robotics market, 2016 – 2026 (USD billion)
7.1.2. Germany
7.1.2.1. Germany Medical Robotics market, 2016 – 2026 (USD billion)
7.1.3. France
7.1.3.1. France Medical Robotics market, 2016 – 2026 (USD billion)
7.1.4. Russia
7.1.4.1. Russia Medical Robotics market, 2016 – 2026 (USD billion)
7.1.5. Italy
7.1.5.1. Italy Medical Robotics market, 2016 – 2026 (USD billion)
7.1.6. Spain
7.1.6.1. Spain Medical Robotics market, 2016 – 2026 (USD billion)

8. MARKET SHARE ANALYSIS
8.1. Regional MRI (Magnetic Resonance Imaging) Market Share Analysis, by Key Players
8.1.1. UK MRI (Magnetic Resonance Imaging) Market Share Analysis, by Key Players
8.1.2. Germany MRI (Magnetic Resonance Imaging) Market Share Analysis, by Key Players
8.1.3. France MRI (Magnetic Resonance Imaging) Market Share Analysis, by Key Players
8.1.4. Russia MRI (Magnetic Resonance Imaging) Market Share Analysis, by Key Players
8.1.5. Italy MRI (Magnetic Resonance Imaging) Market Share Analysis, by Key Players
8.1.6. Spain MRI (Magnetic Resonance Imaging) Market Share Analysis, by Key Players
8.2. MRI (Magnetic Resonance Imaging) Market: Key Innovators
8.3. Patent Analysis Year 2017

9. MARKET COMPETITION ANALYSIS
9.1. Strategy Framework
9.2. Company Profiles
9.2.1. Alliance Medical UK
9.2.1.1. Company overview
9.2.1.2. Key financials
9.2.1.3. Product landscape
9.2.1.4. Strategic initiatives
9.2.1.5. SWOT analysis
9.2.2. Cobalt Health
9.2.2.1. Company overview
9.2.2.2. Key financials
9.2.2.3. Product landscape
9.2.2.4. Strategic initiatives
9.2.2.5. SWOT analysis
9.2.3. InHealth Group
9.2.3.1. Company overview
9.2.3.2. Key financials
9.2.3.3. Product landscape
9.2.3.4. Strategic initiatives
9.2.3.5. SWOT analysis
9.2.4. Vista Diagnostics
9.2.4.1. Company overview
9.2.4.2. Key financials
9.2.4.3. Product landscape
9.2.4.4. Strategic initiatives
9.2.4.5. SWOT analysis
9.2.5. GE Healthcare
9.2.5.1. Company overview
9.2.5.2. Key financials
9.2.5.3. Product landscape
9.2.5.4. Strategic initiatives
9.2.5.5. SWOT analysis
9.2.6. Hitachi Medical Systems
9.2.6.1. Company overview
9.2.6.2. Key financials
9.2.6.3. Product landscape
9.2.6.4. Strategic initiatives
9.2.6.5. SWOT analysis
9.2.7. Global Diagnostics
9.2.7.1. Company overview
9.2.7.2. Key financials
9.2.7.3. Product landscape
9.2.7.4. Strategic initiatives
9.2.7.5. SWOT analysis
9.2.8. Prime Health
9.2.8.1. Company overview
9.2.8.2. Key financials
9.2.8.3. Product landscape
9.2.8.4. Strategic initiatives
9.2.8.5. SWOT analysis
9.2.9. Everlight Radiology
9.2.9.1. Company overview
9.2.9.2. Key financials
9.2.9.3. Product landscape
9.2.9.4. Strategic initiatives
9.2.9.5. SWOT analysis
9.2.10. MR Solutions
9.2.10.1. Company overview
9.2.10.2. Key financials
9.2.10.3. Product landscape
9.2.10.4. Strategic initiatives
9.2.10.5. SWOT analysis
9.2.11. Healtis
9.2.11.1. Company overview
9.2.11.2. Key financials
9.2.11.3. Product landscape
9.2.11.4. Strategic initiatives
9.2.11.5. SWOT analysis
9.2.12. Olea medical
9.2.12.1. Company overview
9.2.12.2. Key financials
9.2.12.3. Product landscape
9.2.12.4. Strategic initiatives
9.2.12.5. SWOT analysis
9.2.13. KOELIS
9.2.13.1. Company overview
9.2.13.2. Key financials
9.2.13.3. Product landscape
9.2.13.4. Strategic initiatives
9.2.13.5. SWOT analysis
9.2.14. Sopha
9.2.14.1. Company overview
9.2.14.2. Key financials
9.2.14.3. Product landscape
9.2.14.4. Strategic initiatives
9.2.14.5. SWOT analysis
9.2.15. Metrasens
9.2.15.1. Company overview
9.2.15.2. Key financials
9.2.15.3. Product landscape
9.2.15.4. Strategic initiatives
9.2.15.5. SWOT analysis
9.2.16. Qualiformed
9.2.16.1. Company overview
9.2.16.2. Key financials
9.2.16.3. Product landscape
9.2.16.4. Strategic initiatives
9.2.16.5. SWOT analysis
9.2.17. INUMAC
9.2.17.1. Company overview
9.2.17.2. Key financials
9.2.17.3. Product landscape
9.2.17.4. Strategic initiatives
9.2.17.5. SWOT analysis
9.2.18. MRI Assist
9.2.18.1. Company overview
9.2.18.2. Key financials
9.2.18.3. Product landscape
9.2.18.4. Strategic initiatives
9.2.18.5. SWOT analysis
9.2.19. Affidea Spain
9.2.19.1. Company overview
9.2.19.2. Key financials
9.2.19.3. Product landscape
9.2.19.4. Strategic initiatives
9.2.19.5. SWOT analysis
9.2.20. Esaote
9.2.20.1. Company overview
9.2.20.2. Key financials
9.2.20.3. Product landscape
9.2.20.4. Strategic initiatives
9.2.20.5. SWOT analysis
9.2.21. Biotronik
9.2.21.1. Company overview
9.2.21.2. Key financials
9.2.21.3. Product landscape
9.2.21.4. Strategic initiatives
9.2.21.5. SWOT analysis
9.2.22. HQ Imaging
9.2.22.1. Company overview
9.2.22.2. Key financials
9.2.22.3. Product landscape
9.2.22.4. Strategic initiatives
9.2.22.5. SWOT analysis
9.2.23. Magritek
9.2.23.1. Company overview
9.2.23.2. Key financials
9.2.23.3. Product landscape
9.2.23.4. Strategic initiatives
9.2.23.5. SWOT analysis
9.2.24. MIPM GmbH
9.2.24.1. Company overview
9.2.24.2. Key financials
9.2.24.3. Product landscape
9.2.24.4. Strategic initiatives
9.2.24.5. SWOT analysis
  • INQUIRE BEFORE BUYING